REZOMAB Bortezomib Injection IP 2mg lyophilized cytotoxic In Pakistan

REZOMAB Bortezomib Injection IP 2mg is a prescription anticancer medicine containing Bortezomib, a proteasome inhibitor used in the treatment of certain blood cancers, particularly multiple myeloma and mantle cell lymphoma. It works by blocking proteasomes, which are cellular protein-processing complexes, leading to the accumulation of abnormal proteins and ultimately the death of cancer cells.

REZOMAB is supplied as a lyophilized powder for reconstitution and must be prepared and administered by trained healthcare professionals under the supervision of a qualified oncologist.

Composition

• Brand Name: REZOMAB

• Active Ingredient: Bortezomib

• Strength: 2mg

• Dosage Form: Lyophilized Powder for Injection

• Pharmacopoeia: IP (Indian Pharmacopoeia)

• Drug Category: Antineoplastic / Proteasome Inhibitor

• Product Type: Cytotoxic Medicine

• Route of Administration: Intravenous or subcutaneous, depending on the prescribed formulation and treatment protocol

Uses of REZOMAB Bortezomib Injection

Bortezomib is used in the treatment of certain hematological malignancies, including:

• Multiple myeloma

• Mantle cell lymphoma

• Other approved indications according to the relevant treatment protocol

It may be prescribed alone or in combination with other anticancer medicines, depending on the patient's diagnosis and treatment history.

How Bortezomib Works

Bortezomib is a proteasome inhibitor. It blocks the activity of proteasomes, which normally break down unwanted or damaged proteins inside cells.

By inhibiting this process, Bortezomib causes abnormal protein accumulation within cancer cells, triggering cellular stress and programmed cell death (apoptosis). This helps control the growth and survival of malignant cells.

Dosage and Administration

The dosage of REZOMAB Bortezomib Injection depends on the patient's body surface area, cancer type, treatment regimen, previous therapy, and overall health.

• Supplied as lyophilized powder requiring reconstitution.

• Administered intravenously or subcutaneously according to the specific product instructions.

• Dosage and treatment schedules are determined by an oncologist.

• Patients may receive Bortezomib as part of combination chemotherapy.

• Regular blood tests and clinical monitoring are required.

Important: This is a cytotoxic prescription medicine. It must only be prepared and administered by trained healthcare professionals. Never self-administer this injection.

Possible Side Effects

REZOMAB Bortezomib may cause side effects, including:

• Nausea and vomiting

• Diarrhea or constipation

• Fatigue and weakness

• Loss of appetite

• Low platelet count

• Low white blood cell count

• Peripheral neuropathy (numbness, tingling, or nerve pain)

• Fever

• Dizziness

• Changes in blood pressure

Serious complications may include severe peripheral neuropathy, infections, liver problems, and tumor lysis syndrome.

Important Precautions

Before starting treatment with Bortezomib, inform the treating oncologist about existing medical conditions, allergies, and all medicines being taken.

Important precautions include:

• Regular monitoring of complete blood counts.

• Assessment of liver function.

• Monitoring for peripheral neuropathy.

• Monitoring for signs of infection.

• Careful assessment of hydration and kidney function.

• Monitoring for tumor lysis syndrome in patients at risk.

Patients should immediately report unusual bleeding, persistent fever, severe abdominal pain, or new or worsening numbness and tingling.

Storage

Store REZOMAB Bortezomib Injection according to the manufacturer's approved storage conditions and product labeling. Protect the medicine from inappropriate temperatures and light where specified.

Reconstituted solution must be handled and stored according to the manufacturer's instructions. As a cytotoxic medicine, it requires appropriate handling and disposal procedures.

REZOMAB Bortezomib Injection IP 2mg In Pakistan

REZOMAB Bortezomib Injection IP 2mg Lyophilized Cytotoxic is available at Onlinetrade.pk in Pakistan, subject to current stock and applicable prescription requirements.

Customers and healthcare professionals can contact Onlinetrade.pk for product availability and ordering information.

Availability in Pakistan

REZOMAB Bortezomib Injection may be available in major cities of Pakistan, including Lahore, Karachi, Islamabad, Rawalpindi, Multan, Faisalabad, Peshawar, Gujranwala, Hyderabad, Bahawalpur, Sialkot, Sukkur, Larkana, and other major cities, subject to stock availability.

Frequently Asked Questions (FAQs)

What is REZOMAB Bortezomib Injection used for?

REZOMAB contains Bortezomib, an anticancer medicine used primarily for treating multiple myeloma and certain cases of mantle cell lymphoma.

What is the strength of REZOMAB Injection?

REZOMAB is supplied as a 2mg lyophilized powder for injection.

What does lyophilized mean?

Lyophilized means the medicine is supplied as a freeze-dried powder that must be reconstituted with an appropriate diluent before administration.

Is REZOMAB a chemotherapy medicine?

Yes. Bortezomib is an antineoplastic medicine classified as a proteasome inhibitor and is used in cancer treatment.

How is Bortezomib administered?

Depending on the approved product instructions and treatment protocol, it can be administered intravenously or subcutaneously by trained healthcare professionals.

Where can I find REZOMAB Bortezomib Injection in Pakistan?

You can check its availability at Onlinetrade.pk, subject to current stock and applicable prescription requirements.